“…22,23,28 Two studies assessed the impact of SCD HRQL (SF-36 20,22,23,26,28 Depression (PHQ 23,25 , PHQ-9 22,28 , BDI-II 29 ) Anxiety (PHQ 25 , GAD-7 22,28 ) Coping strategy (CSQ-SCD) 21 Stress (Sickle cell stress) 26 Sleep disturbance (PSQI) 29 Positive impact on PRO are noted in green shaded box Negative impact on PRO are noted in red shaded box Positive inter-relationship between PROs (e.g., sleep disturbance and depression were positively correlated) Negative inter-relationship between PROs (e.g., SF-36 scores were significantly lower for depressed patients than those who were not) Opioid use 20,26 Hydroxyurea 20 Sickle cell disease 27,29 Healthcare injustice from physician or nurse 21 ≥ 90 MME vs. < 90 MME daily opioid dose 22 High somatic symptom burden 25 on patient's coping strategy, depression, and sleep quality without reporting on HRQL. 21,29 Pain The PiSCES study prospectively evaluated pain using daily diaries in adults with SCD. 6,[23][24][25][26] The study reported that 54% of SCD patients had pain on more than half of total patient-days, confirming considerable levels of pain persist in a substantial proportion of patients with SCD.…”